Skip to main content

In phase III trial, bevacizumab prolongs progression-free survival for ovarian cancer

Primary tabs

View
Get Stamp Tags
Published Locations

Breadcrumb

Home
In phase III trial, bevacizumab prolongs progression-free survival for ovarian cancer

User login

Username

Password

Reset your password

Type	Lead	score